WASHINGTON, Dec. 10, 2024 /PRNewswire/ — Danaher Corporation (NYSE: DHR) announced today that its Board of Directors has approved a regular quarterly cash dividend of $0.27 per share of its common stock, payable on January 31, 2025 to holders of record on December 27, 2024.
ABOUT DANAHER
Danaher is a leading global life sciences and diagnostics innovator, committed to accelerating the power of science and technology to improve human health. Our businesses partner closely with customers to solve many of the most important health challenges impacting patients around the world. Danaher’s advanced science and technology – and proven ability to innovate – help enable faster, more accurate diagnoses and help reduce the time and cost needed to sustainably discover, develop and deliver life-changing therapies. Focused on scientific excellence, innovation and continuous improvement, our approximately 63,000 associates worldwide help ensure that Danaher is improving quality of life for billions of people today, while setting the foundation for a healthier, more sustainable tomorrow. Explore more at www.danaher.com.
SOURCE Danaher Corporation
PARIS and CHICAGO and NASHVILLE, Tenn., April 3, 2025 /PRNewswire/ -- Therapixel, creators of MammoScreen®, a…
TELFORD, Pa., April 3, 2025 /PRNewswire/ -- Innovations in surgical light technology can help ORs…
Business Activity Index at 55.9%; New Orders Index at 50.4%; Employment Index at 46.2%; Supplier…
New Research Highlights the Power of Whole Foods Plant-Based Diets in Burnout Reduction and COVID-19…
Leading clinical outsourcing services organization expands partnership with AI orchestration platform to bring agentic AI…
Behavioral health providers that streamline the insurance verification process improve the patient experience and increase…